Savannah Chrisley
Federal Warning Over GLP-1 Web site
Printed
Savannah Chrisley‘s prescription weight reduction web site is underneath a federal microscope … ‘trigger the FDA warned her about making false and deceptive claims about GLP-1s.
The feds fired off a warning letter, obtained by TMZ, to Savannah final month … advising her that they reviewed her web site GoodGirlRX and located some points.
Particularly, the feds took concern with some claims her firm made regarding compounded semaglutide and tirzepatide merchandise … the FDA did not like that she used the phrases “FDA-approved meds,” “FDA-approved choices” and “clinically confirmed GLP-1 outcomes.”
The feds schooled Savannah, telling her compounded drug merchandise like those her web site presents are NOT FDA-approved … they usually mentioned she was implying that her merchandise had been “evaluated for security and effectiveness after they haven’t.”
Savannah was warned that she was in violation of federal legislation … they usually gave her 15 enterprise days to make corrections or threat authorized motion.
Appears Savannah took the warning severely … it appears like her web site has made some adjustments to conform … for instance, the phrasing now says “clinically studied outcomes” not “clinically confirmed” … and there are disclaimers saying the GLP-1 medicine are usually not FDA-approved.
Savannah tells TMZ … “This was about web site wording, not affected person security. There have been no fines and no disciplinary motion. We’re proud to assist girls entry licensed physicians and we welcome the FDA’s steerage.”
